Follow-The-Filings

Security · featured owners

MYGN Myriad Genetics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 exit

holders

sorted by value · long equity only · current book 2026 Q2 · exits show last held size · open a manager for their book

history
Glenview Capital Management exited 2026 Q2 last 2026 Q1 0.61% Exit −0.61 pp 5,411,978 $24M history

0 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $753.2M $837.6M $824.5M
Gross profit — $585.4M $576.6M
Gross margin * — 69.9% 69.9%
Net income -$263.3M -$127.3M -$365.9M
Net margin * -35.0% -15.2% -44.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $313.6M $298M $332.6M
Total non-current assets * $832.9M $729.6M $374M
Total assets $1.15B $1.03B $706.6M
Total current liabilities $155.9M $164.1M $133.8M
Total non-current liabilities * $207.4M $162.4M $204.8M
Total equity $783.2M $701.1M $368M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$110.9M -$8.7M $1.8M
Cash from investing $31.9M -$11.9M -$27.4M
Cash from financing $152.9M -$7.4M $64.2M
Net change in cash $74.5M -$29M $39.4M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders